Literature DB >> 31728921

The Role of the Dental Community in Oropharyngeal Cancer Prevention Through HPV Vaccine Advocacy.

Thomas Luke Arnell1, Collin York2, Alexis Nadeau2, Maeve Lauren Donnelly2,3, Laura Till2, Pedram Zargari2, Wendy Davis2, Christine Finley4, Thomas Delaney2, Jan Carney2.   

Abstract

As rates of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) continue to rise, the dental community's role in primary prevention efforts related to HPV vaccination will become increasingly important. The aim of this study was to assess knowledge, beliefs, practices, and perceived barriers regarding HPV and HPV vaccine advocacy within the dental community. A sample of 266 dentists and dental hygienists completed an online survey, and responses were then analyzed using frequencies of responses, t tests, chi-square tests, and Spearman's correlations. Ninety percent of providers believe it is important to play an "active role" in their patients' general medical care, yet only 50% believe it is their responsibility to recommend the HPV vaccine. Only 50% feel knowledgeable enough to recommend the vaccine. 78.6% of providers rarely discuss HPV vaccination with their age-appropriate patients, and 82% rarely recommend the vaccine. The two most strongly agreed-upon barriers were "parent concerns about the safety or efficacy of the vaccine" (71.6%) and "parent opposition to HPV vaccination for philosophical or religious reasons" (72.6%). Dentists were more knowledgeable about HPV vaccination and more likely to recommend the vaccine than hygienists. Higher levels of HPV-related knowledge correlated positively with beliefs and practices that support HPV vaccine advocacy. We have identified multiple opportunities for intervention aimed at increasing vaccine advocacy among oral health providers. These include clarification of role from dental professional organizations, alleviation of concerns related to perceived parental objection to the vaccine, and educational interventions targeting knowledge deficits among oral health providers.

Entities:  

Keywords:  Cancer prevention; Dental hygienists; Dentists; Human papillomavirus; Human papillomavirus vaccine; Oropharyngeal cancer; Public health

Year:  2021        PMID: 31728921     DOI: 10.1007/s13187-019-01628-w

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  19 in total

1.  Cervical Cancer Incidence in Young U.S. Females After Human Papillomavirus Vaccine Introduction.

Authors:  Fangjian Guo; Leslie E Cofie; Abbey B Berenson
Journal:  Am J Prev Med       Date:  2018-05-30       Impact factor: 5.043

2.  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Elissa Meites; Allison Kempe; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-16       Impact factor: 17.586

3.  US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Authors:  Mona Saraiya; Elizabeth R Unger; Trevor D Thompson; Charles F Lynch; Brenda Y Hernandez; Christopher W Lyu; Martin Steinau; Meg Watson; Edward J Wilkinson; Claudia Hopenhayn; Glenn Copeland; Wendy Cozen; Edward S Peters; Youjie Huang; Maria Sibug Saber; Sean Altekruse; Marc T Goodman
Journal:  J Natl Cancer Inst       Date:  2015-04-29       Impact factor: 13.506

4.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

Review 5.  Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Maura L Gillison; Anil K Chaturvedi; William F Anderson; Carole Fakhry
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

6.  Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation.

Authors:  S L Rosenthal; T W Weiss; G D Zimet; L Ma; M B Good; M D Vichnin
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

Review 7.  HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

Authors:  Maura L Gillison; Anil K Chaturvedi; Douglas R Lowy
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

8.  Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

Authors:  Elmar A Joura; Sepp Leodolter; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Laura A Koutsky; Suzanne M Garland; Diane M Harper; Grace W K Tang; Daron G Ferris; Marc Steben; Ronald W Jones; Janine Bryan; Frank J Taddeo; Oliver M Bautista; Mark T Esser; Heather L Sings; Micki Nelson; John W Boslego; Carlos Sattler; Eliav Barr; Jorma Paavonen
Journal:  Lancet       Date:  2007-05-19       Impact factor: 79.321

9.  Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.

Authors:  Anil K Chaturvedi; William F Anderson; Joannie Lortet-Tieulent; Maria Paula Curado; Jacques Ferlay; Silvia Franceschi; Philip S Rosenberg; Freddie Bray; Maura L Gillison
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

10.  Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Authors:  Martin Steinau; Mona Saraiya; Marc T Goodman; Edward S Peters; Meg Watson; Jennifer L Cleveland; Charles F Lynch; Edward J Wilkinson; Brenda Y Hernandez; Glen Copeland; Maria S Saber; Claudia Hopenhayn; Youjie Huang; Wendy Cozen; Christopher Lyu; Elizabeth R Unger
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

View more
  4 in total

1.  Dental practitioners' use of health risk assessments for a variety of health conditions: Results from the South Atlantic region of The National Dental Practice-Based Research Network.

Authors:  Stephanie A S Staras; Yi Guo; Valeria V Gordan; Gregg H Gilbert; Deborah L McEdward; Douglas Manning; Jennifer Woodard; Elizabeth A Shenkman
Journal:  J Am Dent Assoc       Date:  2020-12-01       Impact factor: 3.634

2.  A Mixed-Methods Examination of Factors Related to HPV Vaccination Promotion in Private Dental Settings, Iowa, 2019.

Authors:  Natoshia Askelson; Grace Ryan; Susan McKernan; Aaron Scherer; Eliza Daly; Lejla Avdic
Journal:  Prev Chronic Dis       Date:  2021-03-25       Impact factor: 2.830

3.  Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.

Authors:  Denise Guadiana; Nolan M Kavanagh; Cristiane H Squarize
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

4.  Human Papillomavirus (HPV) Vaccine Knowledge, Awareness and Acceptance among Dental Students and Post-Graduate Dental Residents.

Authors:  Steven Kent Mann; Karl Kingsley
Journal:  Dent J (Basel)       Date:  2020-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.